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ScreeningAbstract This study aims to investigate the incidence and determinants of colorec-
tal cancer (CRC) and its screening in District of Columbia (DC), and identify modifi-
able risk factors. Data (2000–2009) from the DC Cancer Registry, Behavioral Risk
Factor Surveillance System (BRFSS-DC) and Surveillance Epidemiology and End
Results (SEER) were used to estimate CRC incidence in eight DC Wards. Risk factors
and CRC screening were analyzed using uni-, bi-, and multivariable statistical meth-
ods with survey procedures in SAS (version 9.2) including binary, unconditional mul-
tivariable logistic regression analysis. Factors measured included stage of diagnosis,
age, gender, race/ethnicity, smoking, alcohol, exercise, body weight, health insur-
ance, education, employment, and income. Over the study time, CRC screening
increased from 48.4% to 68.6%. Mean age at diagnosis was 67 years. CRC incidence
is high in DC. Furthermore, CRC incidence rates in DC below 50 years age were
higher than the SEER18 average. Disparities exist between CRC incidence and
screening among DC Wards. Identified risk factors for CRC are smoking, obesity,
and low physical activity; screening was less prevalent among the uninsured andlthcare
S2 S. Chatterjee et al.low socio-economic group. Local variations in CRC occurrence exist and may vary
from average national experiences. Identification of local regions which vary from
national trends in disease occurrence is important for comprehensive understanding
of the disease in the community.
 2015 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
In the United States (US), colorectal cancer (CRC)
is the third most commonly diagnosed cancer and
the second leading cause of cancer associated
deaths [1]. It is estimated that in 2015, some
132,700 men and women will be diagnosed with
CRC and 49,700 deaths will be attributable to
CRC [2]. CRC cost an estimated 14 billion dollars
in 2010 ($15.27 billion in 2015 inflation adjusted
dollars), accounting for almost 11% of the total
cost of cancer care [3]. Predicted national expen-
ditures in 2020, by phases of care, indicate that
among all major cancers, CRC will have the highest
expenditure in its initial phase of care, despite its
decreasing incidence [3].
Recent incidence and mortality rates of CRC
among adults older than 50 years of age have
declined, but can be improved further. Most CRC
cases arise from premalignant adenomatous polyps
through an adenoma-adenocarcinoma transforma-
tion that takes 7–15 years [4]. CRC can be pre-
vented by early detection and polyp removal [4].
Whereas the 5-year relative survival for CRC
between 2002 and 2008 was approximately 60%
[2], the rate for localized diseases was higher
(90%) [2]. Distant metastasized (Stage IV) tumors
had a 5-year survival of only 11% [2].
The American Cancer Society and the US Multi-
Society Task Force recommend routine CRC screen-
ing for all average risk adults beginning at age
50 years by one of the following options: (1) annual
fecal occult blood test (FOBT) or fecal immuno-
chemical test; (2) 5-yearly flexible sigmoidoscopy;
(3) 10-yearly colonoscopy; (4) 5-yearly double-
contrast barium enema; (5) 5-yearly computed
tomography colonography; or (6) sDNA [5].
CRC incidence rates below the recommended
screening age are increasing [6]. The rise in CRC
incidence among the younger population has been
attributed to behavioral risk factors such as con-
sumption of red meat, lack of physical activity,
smoking, and alcohol consumption [6]. Several
studies have demonstrated a role of lifestyle mod-
ification and reduction of modifiable risk factors in
primary prevention of CRC. The microsimulationCRC screening analysis model (MISCAN-Colon) esti-
mated the impact of historic changes in risk fac-
tors, screening, and treatment on CRC incidence
and mortality trends, and established the role of
physical inactivity, overweight and obesity, and a
diet high in red and processed meat, as major mod-
ifiable risk factors for CRC [7].
The decline in CRC incidence and mortality over
the past few decades has largely been attributed to
increased screening among average risk adults
50 years and older [7]. Access to CRC screening is
likely to increase with The Patient Protection and
Affordable Care Act of 2010. However, the current
screening guidelines do not address CRC in individ-
uals younger than 50 years of age [8], and at this
time, evidence to support population-wide screen-
ing in this age group is weak [8]. With the rising
number of CRC cases in younger adults and a lack
of screening guidelines in this age group, it is
important to pay greater attention to behavioral
risk factors and formulate potential prevention
strategies. Thus, primary prevention of CRC
through screening as well as lifestyle modification
may be an effective strategy for both older and
younger adults [9].
1.1. Status of CRC in Washington DC
The overall 5-year rate changes show a decreasing
trend in incidence of CRC in the District of Colum-
bia (DC) over time, with an estimated annual per-
centage change (APC) of 4.0% from 2003 to
2007. However, despite its declining trend, DC car-
ries one of the highest incidence rates of CRC in the
US [10]. The incidence rate of CRC in DC in 2009
was 43.8/100,000 population as compared with
42.3/100,000 population in the US, and higher than
states such as Arizona, Colorado, Florida, Mary-
land, Oregon, Utah, and Washington (average of
37.2/100,000 population) [11]. The incidence rate
was higher among Blacks as compared with Whites
in DC in 2009 (53.9/100,000 population vs.
24.8/100,000 population) [11].
DC is divided into eight distinct geographical
units called Wards (numbered 1–8) which elect
their representatives as members of the DC City
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tals, and several excellent cancer care services in
DC [12]. However, a high prevalence of cancer con-
tinues to persist in DC, because many of these ser-
vices are neither accessible nor affordable for the
poor and medically underserved (uninsured/
underinsured) DC residents [12]. The divergent
trend in CRC incidence and mortality between
Blacks and Whites in DC has usually been explained
by late stage diagnosis [13], and a complex inter-
play of clinical, social, biological, and environmen-
tal factors [14]. It is therefore important to
understand tumor biology, genetics, and sociode-
mographic and lifestyle risk factors among DC res-
idents to understand these disparities.
1.2. Objectives
Despite the large amount of scientific literature on
CRC, population-based studies in DC describing epi-
demiology, estimate of disease magnitude, its dis-
tribution, and local risk factors are few. Much
undetermined basic CRC epidemiologic information
remains in DC such as estimates of the affected
population in each DC Ward, Ward-specific screen-
ing estimates, small area variations, and modifi-
able risk factors impacting incidence and CRC
outcome. The overall goal of this study was to
study the distribution and determinants of CRC in
DC and its Wards, and to identify geographical
areas and modifiable lifestyle factors as interven-
tion targets. We report the results following the
STROBE guidelines.
2. Methods
Data for this study came from three distinct
sources: (1) the Washington DC cancer registry
(DCCR) (years 2000–2009); (2) the Behavioral Risk
Factor Surveillance System (BRFSS 2002–2008);
and (3) the US Census Bureau. Data from Surveil-
lance Epidemiology and End Results (SEER) were
used for comparison between DC and the SEER-18
states. DCCR collects cancer data on all cancers
diagnosed and/or treated in DC by tracking the
incidence and mortality of all types of cancers.
The DCCR gathers its data from hospitals, laborato-
ries, and other reporting agencies in DC, as well as
its neighboring states, to capture all occurrences of
cancer among DC residents.
Age adjustments were based on the US 2000
population. Cumulative and yearly CRC incidences
were calculated using all CRC cases reported
in the DCCR, with US Census Bureau (2000)DC resident population as the denominator. The
US Census Bureau’s Population Estimates Program
produces estimates of the population and population
changes for the US every year in states, counties,
cities, and towns. With every new annual estimate
release, the entire time series of estimates is revised
for all years back to the last census.
DC Ward-specific CRC screening prevalence
(FOBT and sigmoidoscopy/colonoscopy together
referred to in this report as colonoscopy), and
behavioral and socioeconomic determinants were
analyzed from the BRFSS. Because cases of CRC
are rare below the age of 20 years, analysis was
restricted to populations aged 20 years and above.
This HIPAA-compliant study was cleared by The
George Washington University Institutional Review
Board.2.1. Statistical analysis
The main outcome variable was: receipt of
CRC screening tests (yes/no). Independent
variables included age categories (20–49 years,
50–64 years, 65–74 years, and P75 years),
gender (men/women), health insurance (yes/no),
education (never attended or elementary school,
attended school, college), annual income
(<$50,000, $50,000 to $74,000, P$75,000),
employment (employed, unemployed, others
[retired, housewives, students]) and calculated
body mass index.
We determined associations between variables
using differences between means, odds ratios
(ORs), and 95% confidence intervals (CI) (two-
tailed tests with significance level set at
a = 0.05). Due to the multistage cluster sampling
design of the BRFSS survey (to account for design
effect and obtain appropriate estimates for stan-
dard errors), we conducted our analysis by employ-
ing survey procedures in PC-SAS/STAT (V9.2, SAS
institute, Cary, NC, USA). We generated GIS maps
with appropriate overlays for data display using
ArcGIS (V9.2) software. After univariate analysis
to check for data distribution, completeness and
consistency, we used t tests to compare the mean
differences in CRC incidence between the US and
SEE-18 states and between men and women in
DC. We used Chi-square tests to assess the associa-
tion between independent and outcome variables.
We evaluated prediction of CRC screening prac-
tices by independent variables employing binary,
unconditional multivariable logistic regression
analysis.
Table 1 Demographic characteristics, Ward-wise incidence of and screening for colorectal cancer (CRC) in District of
Columbia (DC) (cumulative: year 2000–2009).
Factor Level n (%) in DC CRC incidence in DCa CRC incidence in the U.S.a Screening
prevalence in DC
Wards (%)
FOBT Colonoscopy
Age groups (y) 20–49 380 (10.8) 13.5 10 – –
50–64 1158 (32.8) 135.1 78.1 – –
65–74 780 (22.1) 217.1 182.6 – –
P75 1213 (34.3) 356.9 302.7 – –
Sex Male 1662 (47.0) 61.7 58 – –
Female 1862 (52.7) 61.5 42.7 – –
Race White 788 (22.4) 44.8 48.6 – –
Black 2432 (69) 71 59.9 – –
Others 304 (8.6) 58.7 40.2 – –
DC Wards Ward 1 325 (9.5) 44.3 – 55.2 66.3
Ward 2 318 (9.3) 46.2 – 63.1 70.6
Ward 3 411 (12.1) 55.7 – 66.7 74.2
Ward 4 507 (14.9) 68.4 – 54.3 68.4
Ward 5 651 (19.1) 90.0 – 50.8 60.7
Ward 6 420 (12.3) 61.7 – 58.2 68.0
Ward 7 442 (13.0) 62.7 – 47.7 63.7
Ward 8 351 (10.3) 49.5 – 40.2 52.4
FOBT = fecal occult blood test.
a Incidence/100,000 populations per year.
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3.1. Distribution of CRC in DC
The 2000–2009 study data file included all 3534
CRC cases reported to the DCCR. Table 1 describes
demographic characteristics of CRC patients in DC.
The highest incidence rate (356.9/100,000) was
seen among those >75 years of age. The incidence
of CRC was highest among Blacks (71.0/100,000 in
Blacks compared with 44.8/100,000 in Whites and
58.7/100,000 among other races).
The incidence of CRC in DC decreased for all
races and genders from 2000 to 2009 (Fig. 1).
Although the incidence of CRC substantially
increased in 2002, it showed a generally decreasing
trend thereafter (from 2003 to 2009). We attribute
this ‘‘spike” to a small number of cases resulting in
unstable rates at times of demographic changes
(between 2000 and 2005, population of Blacks in
DC decreased by 3.24% and those of Whites, Lati-
nos, and other races increased, respectively, by
1.85%, 1.055%, and 2.16%; data available from
the US Census Bureau). The APC in CRC incidence
varied from year to year, with the largest change
(3.5%: data not shown) occurring between 2003
and 2004. The average age adjusted cumulative
incidence of CRC in DC (2002–2009) was signifi-cantly higher than the national average (p = 0.04).
However, on a year-to-year comparison, this dif-
ference disappeared from 2006 onwards (Fig. 1).
Although a sharp rise in cumulative incidence of
CRC was noted among Whites in 2003, this was
not statistically significant (p = 0.08). The CRC inci-
dence in Blacks was significantly higher compared
with Whites (p = 0.03) in DC. The median age of
CRC diagnosis in DC was 65 years in men and
70 years in women. There was no significant differ-
ence in CRC incidence between men and women in
DC (p = 0.89) (Fig. 1).
3.2. Distribution of CRC in Wards
Overall, the cumulative and yearly (2000–2009)
incidence of CRC was highest in Ward 5 (Table 1).
The CRC incidence increased in Ward 5 and Ward
8 between 2007 and 2009. Approximately 29% of
tumors were in Stage IV; 21.2% of these Stage IV
tumors were reported from Ward 5, and 15.4% from
Ward 8. Ward 3 had the lowest prevalence of Stage
IV tumors (7.4%), whereas Ward 8 had the lowest
prevalence of localized tumors (8.5%).
3.3. Distribution of CRC screening in DC
CRC screening analysis included 13,139 BRFSS
respondents who answered questions on FOBT
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Fig. 1 Race and gender distribution of incident colorectal cancer (CRC) in Washington, District of Columbia (DC) and
overall comparison with Surveillance Epidemiology and End Results (SEER) 18, years 2000–2009.
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57.7% of the respondents reported time-interval
appropriate CRC screening by at least one method.
Of those who had FOBT, 48.5% reported having
been tested within 1 year and 94% of colonoscopy
respondents underwent testing in the past 5 years.
DC showed an increasing trend in colonoscopy,
(60.2% in 2002 to 71.2% in 2008), and a slightly
declining trend in FOBT (49.5% in 2002 to 46.5% in
2008). No CRC screening was reported in the
20–49 years age group. The odds of being screened
for CRC with FOBT or colonoscopy were highest
in the 65–74 years age group compared with
50–64 years age group (OR 1.4, 95% CI: 1.2–1.7;
and OR 2.3, CI: 1.9–2.7), and was lower among
the uninsured compared with the insured (FOBT:
OR 0.4, CI: 0.3–0.5; colonoscopy OR 0.3 CI:
0.2–0.4) (Table 2). Despite 92% health insurance
coverage in DC, only 51.8% of DC residents covered
under insurance underwent FOBT and 62.9% under-
went colonoscopy. Screening was significantly less
likely among elementary and high school graduates
as compared with college graduates (FOBT: OR 0.3,
CI: 0.2–0.7 and OR 0.6, CI: 0.5–0.9; colonoscopy:
OR 0.4, CI: 0.3–0.5 and OR 0.6, CI: 0.5–0.7) and
in the low income group compared with the high
income group (OR 0.6, CI: 0.4–0.7 and OR 0.5,
CI: 0.4–0.6).
3.4. Distribution of CRC screening in Wards
Colonoscopy prevalence in eight DC Wards over
years 2002–2008 showed an increasing trend ofscreening prevalence in Ward 1 (58–78.6%), Ward
2 (62.6–76.8%), and Ward 3 (65.9–83.2%); other
Wards showed year-wise fluctuations. Overall,
Ward 3 had the highest (74%) and Ward 8 had the
lowest (51.8%) CRC screening prevalence. Ward 5,
with the highest incidence of CRC, had an overall
screening prevalence of 60.6%. Fig. 2 summarizes
Ward-wise cumulative CRC incidence and screening
prevalence in DC (2000–2009).
3.5. CRC and CRC screening associated risk
factors
Logistic regression analysis (Table 2) suggested
that age group, education, health insurance,
employment, and income were independently
associated with FOBT and colonoscopy screening
in DC. Upon comparing ORs between crude and
multivariable adjusted models, most ORs increased
in the adjusted models (range of increase between
7% and 67% for colonoscopy; and between 10% and
53% for FOBT). The values of the CIs of the effect
estimates and their precision did not change
appreciably.
Some important risk factors associated with CRC
were analyzed according to their prevalence in
eight DC Wards. The population and socio-
demographic characteristics were different across
all Wards (p < 0.0001). Ward 3 had a high propor-
tion of the population older than 65 years
(13.8%), who were mostly Whites (83.6%), with
the highest percentage of college graduates
(79.1%), and a median annual income of $71,875
Table 2 Odds ratios [95% confidence interval (CI)] from binary, unconditional crude, and multivariable (adjusted) logistic
regression analysis for fecal occult blood test (FOBT) and colonoscopy in District of Columbia (DC).
Characteristic Level Crude Adjusted model
FOBT Sigmoid/colonoscopy FOBT Sigmoid/colonoscopy
Age (y) 50–64 1 1 1 1
65–74 1.4 (1.2, 1.7)* 2.3 (1.9, 2.7)* 1.6 (1.4, 1.9)* 2.6 (2.2, 3.0)*
P75 1.1 (0.9, 1.4) 1.6 (1.4, 1.9)* 1.4 (1.1, 1.6)* 1.7 (1.4, 2.1)*
Gender Men 1 1 1
Women 1.0 (0.8, 1.2) 1.0 (0.8, 1.2) 1.1 (0.9, 1.2) 1.2 (1.0, 1.3)
Health insurance Yes 1 1 1 1
No 0.4 (0.3, 0.5)* 0.3 (0.2, 0.4)* 0.6 (0.4, 0.8)* 0.5 (0.4, 0.6) *
Education Elementary 0.3 (0.2, 0.7)* 0.4 (0.3, 0.5) * 0.4 (0.3, 0.6)* 0.4 (0.3, 0.6)*
School 0.6 (0.5, 0.9)* 0.6 (0.5, 0.7)* 0.7 (0.6, 0.9)* 0.6 (0.5, 0.7)*
College 1 1 1 1
Income Low 0.6 (0.4, 0.7)* 0.5 (0.4, 0.6)* 0.6 (0.5, 0.7)* 0.5 (0.4, 0.6)*
Moderate 0.7 (0.5, 0.8)* 0.7 (0.5, 0.8)* 0.7 (0.6, 0.8)* 0.7 (0.5, 0.8)*
High 1 1 1 1
Employment Employed 1 1 1 1
Unemployed 0.6 (0.4, 0.8)* 0.5 (0.4, 0.7)* 0.8 (0.6, 1.1) 0.7 (0.5, 0.9)*
Others 1.0 (0.9, 1.1) 1.3 (1.2, 1.5)* 0.9 (0.8, 1.1) 1.3 (1.1, 1.5)*
* Statistically significant difference from reference group.
Fig. 2 District of Columbia (DC) Ward-wise cumulative distribution (2000–2009) of colorectal cancer (CRC) incidence
and CRC screening prevalence.
S6 S. Chatterjee et al.[15]. The proportion of current smokers in Ward 3
was less as compared with others. In contrast,
Ward 7 (97% Blacks, 43.9% men and 56.1% women,
14% >65 years of age, median annual income of
$30,533) [15] and Ward 8 (92.4% Blacks, 44.8%
men and 55.2% women, 6.4% >65 years of age,median annual income of $25,017) [15] had the
lowest proportion of college graduates (12.6% and
8%), low physical activity levels (90% in Ward 3
vs. 65% in Ward 7, and 67% in Ward 8) and high
prevalence of obesity (72% in Ward 7 and 71% in
Ward 8).
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CRC is the fourth leading cause of cancer in DC,
ranking after prostate, breast, and lung cancers
[12]. Our study shows that incidence of CRC,
although showing an overall decline had increased
among Whites in DC in 2002–2003. This could be
interpreted in context of federal changes in insur-
ance coverage for CRC screening. In July 2001,
the federal government added colonoscopy screen-
ing as a covered service for ‘‘average risk” Medi-
care beneficiaries, thereby equalizing coverage of
tests across all insurance groups [16]. It is also well
documented that in general, more Whites undergo
CRC screening than Blacks [10]. This higher ‘‘back-
ground” colonoscopy screening among Whites may
also explain the Black–White disparity in CRC inci-
dence in DC during that period. Although the rates
of CRC in the US have been declining, Blacks in DC
have not experienced such a decline. CRC inci-
dence in DC was also higher than national figures
for those between 20 and 49 years of age. A recent
large population based study conducted to describe
CRC burden in adults below 50 years of age con-
cluded that almost 8% of CRC cases occurred in per-
sons of this age group [17]. Results of a cancer
surveillance project in Canada were also similar
[18]. In the US, Blacks present with CRC at a
younger age than Whites [19]. Recently, The Amer-
ican College of Gastroenterology recommended a
lower CRC screening age in Blacks from 50 to
45 years because of the lower mean age of CRC
incidence among Blacks [20]. Our observation of
higher CRC incidence in the younger age group in
DC could be due to the proportionately larger Black
population in DC (61.7%). The high incidence of
CRC among the young in DC demonstrates a need
for further exploration of CRC risk factors and
screening practices in this group.
Results of this study have consistently shown the
highest yearly prevalence of CRC in Ward 5 over the
examined 8-year period (86.7% Blacks, 46.7% men
and 53.3% women, 17.8% >65 years of age, median
income of $34,433 annually) [15]. In a recent
study, Oliver et al. [15] discussed a strong associa-
tion of income with colonoscopy procedures,
demonstrating that CRC screening procedures are
low among lower income African American males.
Competing demands within a limited family income
and test-related out-of-pocket costs reduce
patients’ interests in screening [21]. We are thus
able to hypothesize that a difference in preventive
care-seeking behavior may have led to the high
incidence of CRC in Ward 5. Further studies should
be able to test this hypothesis.Data from this study identified Ward-specific
variability for CRC stage of diagnosis. The differ-
ences in stage of tumor diagnosis may be attributa-
ble to delays in diagnosis caused by late patient
presentation, lack of insurance, and low income,
which delay seeking medical care [22]. Previous
studies have shown that Blacks are more likely to
present with late stage tumors than Whites [19].
Our analysis showed that 76% of Stage IV tumors
occurred among Blacks, and the majority were
diagnosed in Ward 5 and Ward 8. This emphasizes
the need to improve awareness about CRC in these
Wards and for more focused efforts to increase
screening and early detection in Ward 5 and Ward 8.
A high prevalence of Stage IV tumors in Ward 8
could also be due to limited screening resources
in this Ward, hindering early diagnosis. Evidence
suggests that physicians are hesitant to order even
a FOBT, if adequate colonoscopy resources are not
available to follow-up the positive FOBT results
[23,24]. Our study findings are consistent with
these reports, as we find a low incidence of CRC
in Ward 8, but a high proportion of Stage IV tumors.
A high-sensitivity FOBT that can detect a majority
of prevalent CRC in an asymptomatic population
can be an acceptable option for CRC screening in
average-risk adults aged 50 years or above in these
Wards if they have colonoscopy resources to follow
up positive FOBT tests.
Current efforts in CRC prevention in the US focus
primarily on screening and removal of any precan-
cerous polyps in individuals at or above 50 years of
age. Because persons below 50 years of age are less
likely to be screened for CRC, attention should be
given to preventing disease in younger adults by
addressing modifiable CRC risk factors. While
increasing physical activity and maintaining a
healthy weight can decrease the risk for CRC by
almost 50% [25], smokers have two- to threefold
elevated risk of colorectal adenoma, which are
precursors of CRC [26]. We identified DC Wards
with a greater prevalence of CRC risk factors. The
highest prevalence of smoking, obesity, and low
physical activity was in Wards 5–8. The confluence
of multiple CRC risk factors could be the main dri-
vers of high CRC incidence in Wards 5, 7, and 8.
CRC screenings using flexible sigmoidoscopy and
colonoscopy have been consistently associated
with lower CRC incidence and mortality [27,28].
Our study showed that health insurance, educa-
tion, employment, and income were independently
associated with CRC screening. Similar findings
were reported from a study conducted in two Dan-
ish counties with unemployment, low income, and
a low level of education seen to be significantly
S8 S. Chatterjee et al.associated with participation in CRC screening [29].
Other studies examining determinants of CRC
screening behavior also documented education,
income, and health insurance to be important
CRC screening predictors [30].
Our study is limited by the fact that comparisons
between data from the BRFSS and DCCR may be
ecological in nature, because the screening and
cancer incidence were not measured in the same
individual or in a cohort study. However, the goal
of this study was to assess screening practices in
DC and not to assess a causal association between
screening and incidence of CRC. The goals of the
study were well addressed. Furthermore, the
BRFSS, being a land line telephonic survey, may
not truly represent the entire DC population or
individual ward populations. Also, data for receipt
of CRC screening were all self-reported and not
confirmed by reviewing medical records. Survey
responses were relatively low for screening and
the BRFSS questionnaire did not distinguish
between diagnostic and screening procedures.
However, this is the first population-based study
in DC evaluating Ward-specific epidemiology of
CRC which provides important information about
CRC status in DC. National level data about disease
incidence are often available and discussed.
Through our study, we were able to demonstrate
that local variations exist and national policies
may not always be applicable to local situations.
It is also possible that disease experiences in speci-
fic communities may vary from national experi-
ences and may even contradict national trends.
Although the overall CRC incidence rate has been
decreasing in the US and DC, CRC incidence rates
increased during the period 2007 to 2009 in Wards
5, 7, and 8 in DC. More recent data are now under
evaluation. Such local variations may also exist in
other metropolitan statistical areas in the US.
Despite improved insurance coverage and access
to care in DC, CRC screening services are underuti-
lized, leading to high incidence and late stage CRC,
with disparities between CRC screening efforts and
CRC incidence in DC. Our study was able to identify
areas in DC for more targeted screening and educa-
tional campaigns and also argue for developing
evidence-based policy making and implementation
for CRC screening in DC.
5. Conclusion
Overall incidence of CRC has declined and whole
CRC screening in DC has increased over time. The
screening progress is slow despite expansion of
insurance coverage. Wards 4, 5, 7, and 8 and theBlack female population in DC need to be targeted
for improved screening practices and healthier life-
style interventions. Ongoing challenges include
lack of public awareness about CRC, its risk fac-
tors, and screening practices. A prudent approach
to disparity eradication should consider causes for
local variations in disease occurrences which are
different from the national average.Conflicts of interest
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